Figure 4 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma por Nicholas T. Younger (14956251)

Outros autores:

Figure 1 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma por Nicholas T. Younger (14956251)

Outros autores:

Figure 2 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma por Nicholas T. Younger (14956251)

Outros autores:

Figure 3 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma por Nicholas T. Younger (14956251)

Outros autores:

Table 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification por Robert L. Hollis (15034814)

Outros autores: “...Alison M. Meynert (14956260)...”

Figure 4 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification por Robert L. Hollis (15034814)

Outros autores: “...Alison M. Meynert (14956260)...”

Figure 3 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification por Robert L. Hollis (15034814)

Outros autores: “...Alison M. Meynert (14956260)...”

Figure 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification por Robert L. Hollis (15034814)

Outros autores: “...Alison M. Meynert (14956260)...”

Figure 5 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification por Robert L. Hollis (15034814)

Outros autores: “...Alison M. Meynert (14956260)...”

Figure 2 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification por Robert L. Hollis (15034814)

Outros autores: “...Alison M. Meynert (14956260)...”